(Q54387375)

29 May 2018

title

Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers. (English)

1 reference

29 May 2018

1 reference

1 reference

Jiake He

1

1 reference

29 May 2018

Zhixia Qiu

2

1 reference

29 May 2018

Ning Li

3

1 reference

29 May 2018

Yang Yu

4

1 reference

29 May 2018

Yang Lu

5

1 reference

29 May 2018

Deen Han

6

1 reference

29 May 2018

Tingting Li

7

1 reference

29 May 2018

Di Zhao

8

1 reference

29 May 2018

Wei Sun

9

1 reference

29 May 2018

Fang Fang

10

1 reference

29 May 2018

Jianheng Zheng

11

1 reference

29 May 2018

Hongwei Fan

12

1 reference

29 May 2018

Xijing Chen

13

1 reference

29 May 2018

publication date

17 February 2011

1 reference

29 May 2018

European Journal of Clinical Pharmacology

published in

1 reference

29 May 2018

volume

67

1 reference

29 May 2018

issue

7

1 reference

29 May 2018

page(s)

701-707

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/s00228-011-0994-7

exact match

0 references

cites work

Clinical pharmacokinetics and pharmacodynamics of repaglinide

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Role of OATP transporters in the disposition of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

SLCO1B1 polymorphism and oral antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Global analysis of genetic variation in SLCO1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

OATP1B1 388A>G polymorphism and pharmacokinetics of pitavastatin in Chinese healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Rifampin decreases the plasma concentrations and effects of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

Genetic polymorphisms of CYP3A4: CYP3A4⁎18 allele is found in five healthy Malaysian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-0994-7

The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma

21 January 2018

1 reference

12 December 2020

Multi-component plasma quantitation of anti-hyperglycemic pharmaceutical compounds using liquid chromatography-tandem mass spectrometry

1 reference

12 December 2020

A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane

1 reference

12 December 2020

Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.

1 reference

12 December 2020

10.1007/S00228-011-0994-7

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018